Skip to main content
Get Matched with a Provider
Medication

Lithium Carbonate (Lithobid, Eskalith)

Lithobid and Eskalith are brand names of lithium carbonate, a psychiatric medication available by prescription only. It belongs to a class of medications called mood stabilizers and is primarily prescribed for bipolar disorder.

Learn About Lithium Carbonate Treatment

Connect with a psychiatric clinician—online or in person—for a comprehensive evaluation. If appropriate, they may discuss whether a treatment like lithium carbonate (Lithobid, Eskalith), a long-established treatment option for mood disorders, could be considered within a carefully monitored care plan.

Schedule an appointment with a Psychiatric Clinician

What Conditions Does Lithium Carbonate Treat?

FDA-Approved Uses:

  • Bipolar I Disorder — acute treatment of manic episodes (as monotherapy); maintenance treatment (as monotherapy)

Common Off-Label Uses:

How Psychiatric Medication Prescription Decisions Are Made

1

Find a psychiatric clinician who meets your needs

You can start by searching our psychiatrist directory to find a qualified provider who is accepting patients.

Option 1

Find a psychiatrist using our psychiatrist directory
Provider Directory

Option 2

You may also choose to locate a nearby clinic and schedule your first appointment in person.

Locations Directory
2

Step 2: Meet one-on-one for a comprehensive psychiatric evaluation

During your first session, a psychiatric clinician will evaluate your symptoms, medical history, and treatment goals. If appropriate, they may discuss whether a medication such as lithium carbonate could be included in your care plan. Treatment decisions always prioritize safety, clinical best practices, and your individual needs.

3

Step 3: Begin treatment and ongoing monitoring

After a personalized treatment plan is created, your provider will monitor your progress and adjust the plan as needed. If medication is part of your care, then, if clinically appropriate, your provider may handle prescription renewals online during or after regular follow-ups as clinically appropriate in accordance with LifeStance treatment protocols.

240+ Insurances Accepted

Aetna
Anthem/Empire BCBS-Medicare, Anthem Blue Cross, Anthem/Empire BCBS, Anthem Blue Cross-Medicare, Anthem BCBS-Medicare, Anthem BCBS
Blue Cross Blue Shield (BCBS)
CareFirst BlueCross BlueShield, CareFirst BlueCross BlueShield-Medicare
Evernorth (Cigna), Evernorth (Cigna) (HealthPartners), Evernorth (Cigna)-Medicare
Highmark Blue Cross Blue Shield, Highmark Blue Shield, Highmark Blue Shield-Medicare, Highmark Blue Cross Blue Shield-Medicare
Kaiser Permanente (Southeast)-Medicare, Kaiser Permanente Washington-Medicare, Kaiser Permanente (SoCal)-Medicare, Kaiser Permanente (Southeast), Kaiser Permanente Washington, Kaiser Permanente (SoCal), Kaiser Permanente (Northwest), Kaiser Permanente (Northwest)-Medicare
Medicare
Optum, UnitedHealthcare, Optum, UnitedHealthcare-Medicare
Providence Health Plan, Providence Health Plan-Medicare
Quartz, Quartz-Medicare
Quest Behavioral Health
Regence BlueCross BlueShield, Regence BlueCross BlueShield-Medicare
Struggling with Bipolar Disorder or Depression?

Struggling with Bipolar Disorder or Depression?

Everyone’s experience with bipolar disorder or depression is different. A psychiatrist may help you find the right treatment path, whether that includes lithium carbonate (Lithobid, Eskalith) or another option that fits your needs. Discuss medication options with your treating provider.

Psychiatric Clinician Directory

FAQs About Lithium Carbonate

Bipolar I disorder, including the acute treatment of manic episodes and long-term maintenance therapy. It is also used off-label as an adjunct for treatment-resistant depression and schizoaffective disorder.

Lithium is a mood stabilizer that affects several signaling systems in the brain involved in emotional regulation, neuronal communication, and stress response. Although lithium has been used in psychiatry since the mid-20th century, its exact mechanism of action is not fully understood, though is clearly complex and not explained by a single pathway. Instead, lithium influences multiple biological processes, like the below examples, that regulate mood stability.

a.) Modulates Neurotransmitters

Lithium alters the activity of several key neurotransmitters that influence mood and emotional regulation. These include:

  • Dopamine – Lithium appears to reduce excessive dopamine activity, which is thought to contribute to manic symptoms.
  • Glutamate – It seems to help regulate glutamate signaling, preventing overstimulation of brain cells.
  • Serotonin – Lithium can increase serotonin activity, which may contribute to mood stabilization and antidepressant effects.

By balancing these neurotransmitter systems, lithium can help reduce the intensity of manic episodes and stabilize mood over time.

b.) Regulates Intracellular Signaling

Lithium affects signaling pathways inside brain cells that control how neurons respond to stimuli.

One of the most studied effects involves the inositol signaling pathway. Lithium inhibits enzymes involved in inositol recycling, which alters second-messenger signaling inside neurons. This mechanism may help stabilize overactive neural circuits associated with mania.

Lithium also inhibits glycogen synthase kinase-3 (GSK-3), an enzyme involved in mood regulation, circadian rhythms, and neuronal plasticity. Suppression of GSK-3 activity is believed to contribute significantly to lithium’s mood-stabilizing effects.

c.) Supports Neuroprotection and Brain Health

Lithium appears to have neuroprotective effects, meaning it may help protect neurons from damage and promote healthy brain function.

Clinical research suggests lithium may:

  • Promote growth of new neurons (neurogenesis)
  • Increase levels of neuroprotective proteins such as BDNF (brain-derived neurotrophic factor)
  • Reduce inflammation and oxidative stress in brain tissue
  • Protect neurons from excitotoxic damage

These effects may help stabilize mood and reduce long-term brain changes associated with bipolar disorder.

d.) Stabilizes Circadian Rhythms

People with bipolar disorder often experience disruptions in sleep and circadian rhythms. Lithium influences biological clock mechanisms in the brain, helping regulate sleep-wake cycles and daily rhythms, which may contribute to improved mood stability.

e.) Reduces Suicide Risk

Lithium is one of the few psychiatric medications consistently associated with reduced suicide risk in people with bipolar disorder and recurrent mood disorders. The reason for this protective effect is not fully understood but may relate to lithium’s combined impact on emotional regulation, impulsivity, and brain signaling systems.

Common side effects of lithium carbonate include tremor (shakiness of the hands), increased thirst and urination, nausea, diarrhea, weight gain, cognitive effects such as memory problems or mental fogginess, and fatigue. Many side effects are related to lithium levels in the blood and may improve with dose adjustments. Because lithium has a narrow range of therapeutic and safe blood levels (“therapeutic window”), regular blood monitoring is essential. Contact your clinician if side effects are severe or persistent.

Lithium carbonate is an FDA-approved prescription medication used at therapeutic doses to treat bipolar disorder and is closely monitored by blood tests.

Lithium orotate is an over-the-counter supplement sold in low doses and is not FDA-approved for the treatment of any medical or psychiatric condition. There is limited clinical research on lithium orotate’s effectiveness or safety for psychiatric conditions, while lithium carbonate has decades of clinical evidence supporting its use. Individuals seeking treatment for bipolar disorder or other mood disorders should consult a psychiatric clinician about FDA-approved treatment options.

Lithium carbonate and lithium citrate are both prescription forms of lithium used to treat bipolar disorder. Lithium carbonate is most commonly prescribed as an oral tablet or capsule (including extended-release formulations). Lithium citrate is available as an oral solution and may be preferred by those who have difficulty swallowing tablets or need a liquid formulation. Both forms require the same careful blood monitoring. Your prescribing clinician will determine which formulation is most appropriate based on your individual needs.

Lithobid is an extended-release (ER) formulation of lithium carbonate, while immediate-release lithium carbonate is the standard tablet or capsule. Lithobid is designed to release lithium more slowly over time, which may result in more stable blood levels and potentially fewer side effects such as tremor and gastrointestinal upset. Immediate-release lithium carbonate is typically taken multiple times daily. Your prescribing clinician will recommend the formulation that best fits your treatment needs and lifestyle.

When people refer to “lithium” as a psychiatric medication, they are almost always referring to lithium carbonate or another lithium salt (such as lithium citrate). Lithium is the active element in these compounds. Lithium carbonate is simply the specific salt form most commonly prescribed. The terms are often used interchangeably in clinical settings.

There is research that suggests lithium may have neuroprotective effects that could reduce the risk of dementia. Several observational studies and clinical trials have found that people treated with lithium for mood disorders may have lower rates of Alzheimer’s disease and other dementias compared with those who are not taking lithium.

Lithium carbonate dosing is highly individualized and is determined by your prescribing clinician based on your blood lithium levels, clinical response, and tolerability. Dosing must be carefully managed to keep blood levels within the therapeutic range. Do not adjust your dose without consulting your prescribing clinician.

For acute manic episodes, some improvement may be noticeable within 1–2 weeks of starting lithium carbonate. Full stabilization of mood and the full benefit for long-term maintenance may take several weeks to months. Regular follow-ups with your clinician are important to monitor your response and adjust your care plan as needed.

Regular blood tests are essential when taking lithium carbonate. Because lithium has a narrow therapeutic window (i.e., range of therapeutic and safe blood levels), periodic monitoring of serum lithium levels is required to ensure the medication remains effective without reaching toxic levels. Your clinician will also typically monitor kidney function and thyroid function, as lithium can affect both organs over time. Your clinician will determine how frequently blood tests are needed based on your individual situation.

Weight gain is a commonly reported side effect of lithium carbonate. Increased appetite, fluid retention, and changes in metabolism can contribute to weight changes in some individuals. Not everyone will experience weight gain, and the degree varies between individuals. Speak with your prescribing clinician if weight changes are a concern so they can discuss with you strategies to manage this side effect.

Try to avoid alcohol while on lithium carbonate. Alcohol can affect lithium levels in the blood, potentially increasing the risk of lithium toxicity. It can also worsen side effects such as dizziness, cognitive impairment, and tremor, and may interfere with the effectiveness of the medication. Always discuss alcohol use with your prescribing clinician.

Lithium toxicity can occur when blood levels rise too high, which can happen due to dehydration, changes in sodium intake, or interactions with other medications (particularly NSAIDs and certain blood pressure medications). Early signs of toxicity include coarse tremor, nausea, vomiting, diarrhea, drowsiness, confusion, and muscle weakness. Severe toxicity can lead to seizures, cardiac arrhythmia, and other serious complications. If you experience these symptoms, immediately contact your prescribing clinician or seek emergency care.

Your symptoms may return, especially if it is stopped suddenly. Some people may also experience a rebound of mood symptoms, such as depression or mania. Always follow your psychiatric provider’s directions on when to stop taking medications or change dosages.

No. Lithium carbonate is not a controlled substance. It is a prescription-only medication, meaning it requires a clinician’s prescription to obtain, but it is not classified as a controlled substance by the Drug Enforcement Administration (DEA).

Yes. Several medications can affect lithium levels in the body. Common interactions include:

  • Nonsteroidal anti-inflammatory drugs (NSAIDs)
  • Diuretics (“water pills”)
  • Certain blood pressure medications such as ACE inhibitors
  • Some antidepressants and antipsychotics

Always consult your prescribing psychiatric clinician before starting or stopping any medication while taking lithium.

Lithium is widely known for its long-term treatment when monitored by a prescribing clinician appropriately. Regular medical follow-ups and blood tests help ensure the medication is less likely to cause side effects.

The cost of lithium carbonate varies depending on whether you receive the generic or a brand-name version (Lithobid or Eskalith) and on dosage. As of publication date, potential pricing is listed below.

Generic lithium carbonate:
For a 100-capsule supply:

  • 150 mg lithium oral capsules start around $12.24 for 100 capsules (about $0.12 per capsule).
  • 300 mg lithium oral capsules start around $13.26 for 100 capsules (about $0.13 per capsule).
  • 600 mg lithium oral capsules start around $19.31 for 100 capsules (about $0.19 per capsule).

Prices can vary by location, pharmacy, and discount program.

Brand-name Lithobid: Lithobid is the extended-release brand version of lithium carbonate.
As of publication date, Lithobid 300 mg extended-release tablets start around $1,235.27 for 100 tablets, or about $12.35 per tablet.

If you have insurance, your out-of-pocket cost will depend on your supporting diagnosis and plan type (e.g., commercial, Medicare, Medicaid) and may include a copay or coinsurance.

Medically Reviewed By:

Joshua Nathan, MD
View Profile
Dr. Joshua Nathan, a Board-Certified Psychiatrist, and a Distinguished Fellow of the American Psychiatric Association, sees stigma – from others and from ourselves - as the biggest challenge in mental illness treatment. He encourages people to not judge themselves on whatever problems they are facing, and he helps them feel safe to open up and allow for healing. Dr. Nathan takes joy in helping people with mental health concerns and values the trust patients place in him. Dr. Nathan treats adults struggling with mood and bipolar disorders, depression, ADHD, anxiety challenges such as panic disorder, agoraphobia, OCD, PTSD, and more. He listens to each person’s story, observes how they are faring, and shares his understanding of what is happening, so there is a basis for starting or continuing treatment. He considers medications as one tool among many for healing and recovery in mental health. During treatment, Dr. Nathan uses an eclectic framework for understanding mental illness and coping. Trained in psychoanalysis, he finds that existential understanding helps many people reduce suffering, but cognitive-behavioral techniques are more practical in helping people move forward. Thus, he typically employs a combination of theories and techniques, guided by the patient's problems, needs, and experiences. He is also an Official ADHD Evaluator for the National Football League. Dr. Nathan earned an undergraduate degree from the University of Illinois at Urbana-Champaign, a medical doctorate from the University of Illinois at Chicago, and completed postgraduate residency training at Brown University. He works with adults of all ages, but has a special fondness for working with young and middle-age adults.

References

  1. Drugs.com [Internet]. Lithium carbonate prices, coupons, copay cards & patient assistance; c2000–2025 [updated date unknown; cited 11 Jun 2026]. Available from: https://www.drugs.com/price-guide/lithium-carbonate

  2. Drugs.com [Internet]. Lithobid prices, coupons, copay cards & patient assistance; c2000–2025 [updated date unknown; cited 11 Jun 2026]. Available from: https://www.drugs.com/price-guide/lithobid

  3. Forlenza OV, De-Paula VJ, Diniz BS. Neuroprotective effects of lithium: implications for the treatment of Alzheimer’s disease and related neurodegenerative disorders. ACS Chem Neurosci. 2014 Jun 18;5(6):443-50. doi: 10.1021/cn5000309. Epub 2014 May 6. PMID: 24766396; PMCID: PMC4063497.

  4. Henssler, Jonathan et al. (2024) Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysis. The Lancet Psychiatry, Volume 11, Issue 7, 526–535.

  5. Ishii N, Terao T, Hirakawa H. The Present State of Lithium for the Prevention of Dementia Related to Alzheimer’s Dementia in Clinical and Epidemiological Studies: A Critical Review. Int J Environ Res Public Health. 2021 Jul 22;18(15):7756. doi: 10.3390/ijerph18157756. PMID: 34360049; PMCID: PMC8345730.https://pmc.ncbi.nlm.nih.gov/articles/PMC8345730/

  6. Pfeffer, C. R. (2007). The FDA pediatric advisories and changes in diagnosis and treatment of pediatric depression. American Journal of Psychiatry, 164(6), 843–846. https://doi.org/10.1176/ajp.2007.164.6.843

  7. Sarai SK, Mekala HM, Lippmann S. Lithium Suicide Prevention: A Brief Review and Reminder. Innov Clin Neurosci. 2018 Nov 1;15(11-12):30-32. PMID: 30834169; PMCID: PMC6380616.https://pmc.ncbi.nlm.nih.gov/articles/PMC6380616/

  8. U.S. Food & Drug Administration. (n.d.). Drugs@FDA database. Retrieved March 7, 2026, from https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm

In 2007, the FDA released a black box warning that antidepressants were correlated to the risk of suicidal thinking and behavior in children, adolescents, and young adults (ages 18–24) during short-term studies of major depressive disorder (MDD) and other psychiatric conditions. Gibbons et. al (2007) also published a study that found no evidence of antidepressant treatment increasing the risk of suicide attempts among its patients (ages 18–65+). The main message is that there is an inherent relationship between depression and suicidality so close monitoring of antidepressant-treated patients (especially children, adolescents, and young adults) is always necessary. For a comprehensive overview of these medications’ uses and risks, see the U.S. Food and Drug Administration (FDA) drug label.

Medications are prescribed only when clinically appropriate and should be taken only as directed by a licensed clinician.